Amrize Ltd (NYSE:AMRZ - Get Free Report) passed below its 50 day moving average during trading on Friday after JPMorgan Chase & Co. lowered their price target on the stock from $48.00 to $46.00. The stock has a 50 day moving average of $39.17 and traded as low as $39.04. JPMorgan Chase & Co. currently has a neutral rating on the stock. Amrize shares last traded at $39.06, with a volume of 3,761,149 shares changing hands.
AMRZ has been the subject of several other reports. Jefferies Financial Group lowered shares of Amrize from a "hold" rating to an "underperform" rating and dropped their price objective for the stock from $42.80 to $35.20 in a research note on Monday. Weiss Ratings downgraded shares of Amrize from a "hold (c-)" rating to a "sell (d+)" rating in a research note on Thursday, October 8th. Oppenheimer reduced their target price on shares of Amrize from $55.00 to $52.00 and set an "outperform" rating on the stock in a research note on Monday, November 2nd. Berenberg Bank lowered shares of Amrize from a "buy" rating to a "hold" rating and lowered their target price for the stock from $48.00 to $46.00 in a report on Monday, November 9th. Finally, Bank of America cut shares of Amrize from a "neutral" rating to an "underperform" rating and dropped their price target for the stock from $50.00 to $40.00 in a research note on Wednesday, September 2nd. Eight investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and five have assigned a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $47.07.
View Our Latest Report on Amrize
Insider Buying and Selling at Amrize
In other news, CEO Jan Jenisch bought 4,000 shares of the stock in a transaction on Wednesday, September 2nd. The stock was acquired at an average cost of $42.50 per share, for a total transaction of $170,000.00. Following the acquisition, the chief executive officer owned 519,000 shares of the company's stock, valued at $22,057,500. This represents a 0.78% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Jacques Sanche purchased 4,150 shares of the company's stock in a transaction dated Wednesday, August 26th. The shares were purchased at an average cost of $45.02 per share, for a total transaction of $186,833.00. Following the transaction, the director directly owned 9,766 shares in the company, valued at approximately $439,665.32. This represents a 73.90% increase in their position. The SEC filing for this purchase provides additional information. Insiders acquired a total of 34,155 shares of company stock valued at $1,461,276 over the last quarter. Company insiders own 0.54% of the company's stock.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently added to or reduced their stakes in AMRZ. National Pension Service boosted its holdings in shares of Amrize by 7.5% in the 2nd quarter. National Pension Service now owns 1,493,022 shares of the company's stock valued at $79,578,000 after buying an additional 103,962 shares in the last quarter. Ancora Advisors LLC raised its stake in shares of Amrize by 22.9% during the 2nd quarter. Ancora Advisors LLC now owns 283,522 shares of the company's stock worth $15,112,000 after acquiring an additional 52,759 shares in the last quarter. Engle Capital Management L.P. bought a new position in shares of Amrize during the 1st quarter worth approximately $3,742,000. Renaissance Technologies LLC lifted its position in Amrize by 10.4% during the first quarter. Renaissance Technologies LLC now owns 1,956,600 shares of the company's stock valued at $109,609,000 after acquiring an additional 183,900 shares during the last quarter. Finally, Punch & Associates Investment Management Inc. purchased a new stake in Amrize during the first quarter valued at approximately $8,864,000.
Amrize Price Performance
The stock's 50-day moving average is $39.17 and its 200 day moving average is $49.65. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.07 and a quick ratio of 0.67. The company has a market cap of $21.60 billion, a PE ratio of 17.67, a PEG ratio of 1.59 and a beta of 0.04.
Amrize (NYSE:AMRZ - Get Free Report) last posted its quarterly earnings data on Wednesday, October 28th. The company reported $1.05 earnings per share for the quarter, hitting analysts' consensus estimates of $1.05. Amrize had a return on equity of 10.02% and a net margin of 9.93%. The firm had revenue of $3.77 billion during the quarter. During the same period in the previous year, the business earned $0.98 EPS. The firm's revenue for the quarter was up 2.6% compared to the same quarter last year. On average, equities analysts anticipate that Amrize Ltd will post 2.30 earnings per share for the current fiscal year.
Amrize Dividend Announcement
The firm also recently declared a dividend, which was paid on Wednesday, November 18th. Stockholders of record on Tuesday, November 10th were paid a dividend of $0.11 per share. The ex-dividend date was Tuesday, November 10th. Amrize's payout ratio is presently 4.98%.
About Amrize
(
Get Free Report)
Amrize is a North American building materials and construction solutions company serving customers across the United States and Canada. Its operations span the construction materials and building envelope markets. The company supplies cement, aggregates, ready-mix concrete and asphalt, as well as roofing and other building-envelope products and services. These materials and solutions support residential, commercial and infrastructure projects. Amrize became an independent publicly traded company in 2025 through the spin-off of Holcim's North American business.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Amrize, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amrize wasn't on the list.
While Amrize currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.